Valerie Theobald is the Director of Immunoanalytical Services at our Worcester, MA site. She is responsible for the development, implementation, and oversight and of immunoanalytical methods and technologies for anti-drug antibodies, PK, and biomarkers for both regulated and non-regulated studies.
Valerie previously held bioanalytical leadership positions at Shire and Sanofi-Genzyme, where she was responsible for the shaping and execution of bioanalytical portfolios supporting a wide variety of therapeutic areas and molecular modalities. These includes recombinant proteins, monoclonal antibodies, cell-based therapies, gene-therapies, ASO therapies, and biosimilar therapeutics.
Valerie has a Bachelor’s degree in medical technology from Fitchburg State University. She is an active member of the bioanalytical community, contributing to peer-reviewed white papers, developing workshops, and presenting scientific talks.